Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ISO Issues First Application-Specific Standard on Small Bore Connectors, Others In Pipeline

This article was originally published in SRA

Executive Summary

The International Organization for Standardization (ISO) has issued the first standard in a series of application-specific standards for improving the safety of medical device connectors in clinical settings1.

You may also be interested in...



New ISO Standard For Small-Bore Connectors Focuses On Safety Of Intravenous Delivery

The new ISO standard specifies dimensions and requirements for the design and functional performance of small-bore connectors for use in intravascular or hypodermic applications of medical devices and accessories. It includes new terms of conditions to better define the types of connectors.

Simplified Clinical Trial Transparency Rules To Go Live In The EU In June

A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules. 

WHO Examines Ethical Criteria For Human Challenge Trials Ahead Of Next Health Emergency

The World Health Organization is looking to finalize its guidance on the ethical criteria that should be applied to studies that involve deliberately infecting healthy individuals to speed up research.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT040753

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel